Test Price
2,800 AED✅ Home Collection Available
HGF Gene Deafness (Autosomal Recessive Type 39) Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015, Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, ensuring sample integrity from 8 AM – 11 PM daily.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-licensed genetic counselor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
- Corporate Oversight: Managed by DNA Labs UAE, operating under DHA Facility License No. 1143 in Dubai Healthcare City.
Test Overview & Methodology
This advanced genetic test utilizes Next-Generation Sequencing (NGS) to detect pathogenic variants in the HGF gene, enabling precise diagnosis of autosomal recessive deafness type 39 (sensorineural hearing loss). The comprehensive analysis covers all coding regions and splice sites, significantly outperforming targeted mutation panels that only screen for known hotspots.
| Feature | Our Test (NGS, ISO-Certified) | Closest Alternative (Targeted Mutation Panel) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity for all HGF coding regions | Detects only known point mutations; misses novel variants |
| Methodology | Next-Generation Sequencing (NGS) with bioinformatics analysis | PCR-based Sanger sequencing of limited hotspots |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks (variable) |
| Regulatory Compliance | DHA/MOHAP, ISO 9001:2015, UAE PDPL-compliant data privacy | Variable; often lacks UAE-specific accreditation |
Physician Insight & Safety Protocols
"As a DHA-licensed Consultant Medical Geneticist, I emphasize that a genetic diagnosis is a foundational piece of understanding hereditary hearing loss. It is crucial to correlate these findings with comprehensive audiological assessments and a detailed family pedigree. Our team provides structured post-test counseling to integrate this knowledge into your child's care plan effectively. You are not alone in this journey." — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID 9294403
Safety Protocols & Patient Preparation
- Pre-test genetic counseling is mandatory. Our DHA-licensed counselor will review your family history and coordinate the sample collection.
- Do not discontinue any prescribed medications without consulting your referring physician. This test is for diagnostic clarification and does not replace clinical treatment decisions.
- No special dietary restrictions or fasting is required for the blood draw.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not intended for asymptomatic individuals without a family history of hearing loss. A pre-test genetic counseling session is mandatory to confirm appropriateness.
- Emergency: If you or your child experiences sudden hearing loss, acute vertigo, or neurological symptoms (e.g., facial weakness, slurred speech), seek immediate emergency care rather than scheduling this test.
Patient FAQ & Clinical Guidance
1. What is the HGF gene deafness test, and who should consider it?
This NGS test analyzes the HGF gene to diagnose autosomal recessive deafness type 39. It is recommended for individuals with congenital or early-onset sensorineural hearing loss, particularly those who have failed newborn hearing screening or have a family history of undiagnosed deafness. A referral from an ENT specialist or clinical geneticist is advised for eligibility.
2. How should I prepare for the test, and is genetic counseling mandatory?
Yes, a mandatory pre-test genetic counseling session with a DHA-licensed specialist is required. This session includes drawing a detailed pedigree and reviewing family history. No fasting or medication changes are needed. The test accepts a simple peripheral whole blood sample, extracted DNA, or dried blood spot on an FTA card, collectable via our VIP mobile phlebotomy service.
3. When can I expect my results, and how will they be delivered?
Results are typically available within 3 to 4 weeks. You will receive a comprehensive English-language report. A telephonic consultation with a DHA-licensed genetic counselor is scheduled to guide you through the clinical implications and next steps. We guarantee complete confidentiality and data privacy under UAE law.
UAE Regulatory & Data Privacy Adherence
Security and compliance are foundational to our operations. DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our DHA-licensed facility (License No. 1143) in Dubai Healthcare City ensures that all clinical data is encrypted, securely stored, and processed under strict confidentiality agreements. Clinical safety and patient consent protocols are aligned with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | HGF Gene Deafness (Autosomal Recessive Type 39) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral), Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) with Bioinformatics Analysis |
| ICD-10-CM Code | H90.3 (Sensorineural hearing loss, bilateral) |
| LOINC Code | 21631-6 (Hearing loss gene panel) |
| DHA License & Lab Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Brand: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians